| HGNC Family | EF-hand domain containing |
| Name | nucleobindin 2 |
| Description | This gene encodes a protein with a suggested role in calcium level maintenance, eating regulation in the hypothalamus, and release of tumor necrosis factor from vascular endothelial cells. This protein binds calcium and has EF-folding domains. [provided by RefSeq, Oct 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNUCB2, the precursor of nesfatin‐1, has emerged as a pivotal regulator of energy balance and nutrient homeostasis. In metabolic tissues, including adipose depots, pancreatic islets, gastric X/A‐like cells, and even in breast milk, NUCB2/nesfatin‐1 is dynamically expressed and secreted in response to nutritional status and obesity. Its release modulates satiety, food intake, and glycemic control by influencing insulin and glucagon secretion while also being linked to non‐alcoholic fatty liver disease. These findings highlight NUCB2’s central role in orchestrating inter‐organ communication in energy homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its metabolic functions, NUCB2/nesfatin‐1 contributes to the regulation of endocrine and reproductive processes and the modulation of neurobehavioral responses. Its expression in pancreatic islets and adrenal tissue supports hormonal control, while in reproductive organs such as the testes and ovaries, gonadotropin‐regulated NUCB2/nesfatin‐1 influences steroidogenesis and cell function. Altered levels have been observed in neuropsychiatric conditions such as epilepsy, anxiety, and depression—with evidence for sex‐specific regulatory patterns—as well as in conditions of anorexia nervosa. These studies indicate that beyond energy homeostasis, NUCB2/nesfatin‐1 is intricately involved in stress responsiveness and neuroendocrine integration."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent evidence further implicates NUCB2/nesfatin‐1 in pathological conditions including oncogenesis, cardiovascular dysfunction, and inflammatory diseases. In various malignancies—such as ovarian, prostate, breast, endometrial, and colon cancers—NUCB2/nesfatin‐1 appears to modulate cell proliferation, apoptosis, and epithelial–mesenchymal transition, thereby impacting tumor growth and metastatic potential. In parallel, its cardioprotective properties have been linked to modulation of key intracellular cascades (e.g. Akt/GSK‐3β and LKB1/AMPK/TORC1 pathways), while its levels are altered in type 2 diabetes, chronic obstructive pulmonary disease, and even in response to exercise. Additionally, emerging reports describe its therapeutic potential in attenuating myocardial infarction, melanoma stress adaptation, and acute lung injury."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, NUCB2 function is further refined by regulatory mechanisms such as caspase‐mediated cleavage and calcium‐dependent interactions that affect its bioactivity and interaction with signaling partners—for example, in the modulation of TNF receptor shedding. This layer of post‐translational regulation underscores the complexity of NUCB2’s role and its context‐dependent actions in both physiological and pathological states."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kylie S Foo, Hanna Brauner, Claes-Göran Ostenson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Endocrinol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/JOE-09-0254"}], "href": "https://doi.org/10.1677/JOE-09-0254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20032201"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20032201"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Manjunath Ramanjaneya, Jing Chen, James E Brown, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2009-1358"}], "href": "https://doi.org/10.1210/en.2009-1358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20427481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20427481"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Suleyman Aydin "}, {"type": "b", "children": [{"type": "t", "text": "The presence of the peptides apelin, ghrelin and nesfatin-1 in the human breast milk, and the lowering of their levels in patients with gestational diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2010.08.021"}], "href": "https://doi.org/10.1016/j.peptides.2010.08.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20813143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20813143"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bee K Tan, Manfred Hallschmid, Werner Kern, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2010-1782"}], "href": "https://doi.org/10.1210/jc.2010-1782"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21252251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21252251"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Doreen Zegers, Sigri Beckers, Ilse L Mertens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2011.03.007"}], "href": "https://doi.org/10.1016/j.ymgme.2011.03.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21459029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21459029"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Z Zhang, L Li, M Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Clin Endocrinol Diabetes (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/s-0031-1286339"}], "href": "https://doi.org/10.1055/s-0031-1286339"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22020667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22020667"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Omer Başar, Erdem Akbal, Seyfettin Köklü, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Scand J Clin Lab Invest (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/00365513.2012.699097"}], "href": "https://doi.org/10.3109/00365513.2012.699097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22950627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22950627"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ayhan Abaci, Gonul Catli, Ahmet Anik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Diabetes (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/pedi.12009"}], "href": "https://doi.org/10.1111/pedi.12009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23346951"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23346951"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Andreas Stengel, Tobias Hofmann, Miriam Goebel-Stengel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ghrelin and NUCB2/nesfatin-1 are expressed in the same gastric cell and differentially correlated with body mass index in obese subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histochem Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00418-013-1087-8"}], "href": "https://doi.org/10.1007/s00418-013-1087-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23515787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23515787"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Suleyman Aydin, Ersel Dag, Yusuf Ozkan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-009-0073-x"}], "href": "https://doi.org/10.1007/s11010-009-0073-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19262995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19262995"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bernard Bloem, Lu Xu, Eva Morava, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sex-specific differences in the dynamics of cocaine- and amphetamine-regulated transcript and nesfatin-1 expressions in the midbrain of depressed suicide victims vs. controls."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropharmacology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuropharm.2011.07.023"}], "href": "https://doi.org/10.1016/j.neuropharm.2011.07.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21803054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21803054"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Matteo Riva, Marloes Dekker Nitert, Ulrikke Voss, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Tissue Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00441-011-1268-5"}], "href": "https://doi.org/10.1007/s00441-011-1268-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22108805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22108805"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Mehmet Aslan, Onder Celik, Nilufer Celik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrine (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12020-011-9577-8"}], "href": "https://doi.org/10.1007/s12020-011-9577-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22203468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22203468"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Artur Pałasz, Marek Krzystanek, John Worthington, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1, a unique regulatory neuropeptide of the brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2011.12.002"}], "href": "https://doi.org/10.1016/j.npep.2011.12.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22225987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22225987"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "D García-Galiano, R Pineda, T Ilhan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2011-2032"}], "href": "https://doi.org/10.1210/en.2011-2032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22334726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22334726"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Tobias Hofmann, Andreas Stengel, Anne Ahnis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychoneuroendocrinology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.psyneuen.2013.05.013"}], "href": "https://doi.org/10.1016/j.psyneuen.2013.05.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23796625"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23796625"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hongtuan Zhang, Can Qi, Liang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical significance of NUCB2 mRNA expression in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-9966-32-56"}], "href": "https://doi.org/10.1186/1756-9966-32-56"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23958433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23958433"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "A Stengel, M Mori, Y Taché "}, {"type": "b", "children": [{"type": "t", "text": "The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Obes Rev (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/obr.12063"}], "href": "https://doi.org/10.1111/obr.12063"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23980879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23980879"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Hongtuan Zhang, Can Qi, Andi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-013-1268-z"}], "href": "https://doi.org/10.1007/s13277-013-1268-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24092574"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24092574"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Manjunath Ramanjaneya, Bee K Tan, Marcin Rucinski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 inhibits proliferation and enhances apoptosis of human adrenocortical H295R cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/JOE-14-0496"}], "href": "https://doi.org/10.1530/JOE-14-0496"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25869615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25869615"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Tobias Hofmann, Ulf Elbelt, Anne Ahnis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sex-specific regulation of NUCB2/nesfatin-1: Differential implication in anxiety in obese men and women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychoneuroendocrinology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.psyneuen.2015.06.014"}], "href": "https://doi.org/10.1016/j.psyneuen.2015.06.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26143537"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26143537"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Tobias Hofmann, Anne Ahnis, Ulf Elbelt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NUCB2/nesfatin-1 Is Associated with Elevated Levels of Anxiety in Anorexia Nervosa."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0132058"}], "href": "https://doi.org/10.1371/journal.pone.0132058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26162003"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26162003"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Wei-Jei Lee, Chih-Yen Chen, Kong-Han Ser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/13816128113198880010"}], "href": "https://doi.org/10.2174/13816128113198880010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23768444"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23768444"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Lifeng Jiang, Jiapeng Bao, Xindie Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased serum levels and chondrocyte expression of nesfatin-1 in patients with osteoarthritis and its relation with BMI, hsCRP, and IL-18."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mediators Inflamm (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2013/631251"}], "href": "https://doi.org/10.1155/2013/631251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24259949"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24259949"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Ghada M Anwar, Gamal Yamamah, Amani Ibrahim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2013.12.001"}], "href": "https://doi.org/10.1016/j.regpep.2013.12.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24333832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24333832"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Hongtuan Zhang, Can Qi, Andi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-9966-32-77"}], "href": "https://doi.org/10.1186/1756-9966-32-77"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24422979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24422979"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Morena Scotece, Javier Conde, Vanessa Abella, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NUCB2/nesfatin-1: a new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jor.22585"}], "href": "https://doi.org/10.1002/jor.22585"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24464950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24464950"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Sirpa Leivo-Korpela, Lauri Lehtimäki, Mari Hämälainen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mediators Inflamm (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2014/232167"}], "href": "https://doi.org/10.1155/2014/232167"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24891763"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24891763"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Sajad Ahmadizad, Alireza Salimi Avansar, Khosrow Ebrahim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effects of short-term high-intensity interval training vs. moderate-intensity continuous training on plasma levels of nesfatin-1 and inflammatory markers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Horm Mol Biol Clin Investig (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/hmbci-2014-0038"}], "href": "https://doi.org/10.1515/hmbci-2014-0038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25581765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25581765"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Kiyoshi Takagi, Yasuhiro Miki, Sota Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.EJ15-0490"}], "href": "https://doi.org/10.1507/endocrj.EJ15-0490"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26842712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26842712"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jung-Yu Kan, Meng-Chi Yen, Jaw-Yuan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9140"}], "href": "https://doi.org/10.18632/oncotarget.9140"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27150059"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27150059"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "S Algul, Y Ozkan, O Ozcelik "}, {"type": "b", "children": [{"type": "t", "text": "Serum nesfatin-1 levels in patients with different glucose tolerance levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Physiol Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.33549/physiolres.933186"}], "href": "https://doi.org/10.33549/physiolres.933186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27539099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27539099"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Arda Tasatargil, Nilay Kuscu, Selvinaz Dalaklioglu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: Role of the Akt/GSK-3β pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2017.07.003"}], "href": "https://doi.org/10.1016/j.peptides.2017.07.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28720397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28720397"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Ting Zhai, Shi-Zhen Li, Xin-Tong Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Diabetes Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2017/7687098"}], "href": "https://doi.org/10.1155/2017/7687098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29445751"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29445751"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Qing-Bo Lu, Hui-Ping Wang, Zi-Han Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Basis Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2018.04.002"}], "href": "https://doi.org/10.1016/j.bbadis.2018.04.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29627363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29627363"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Dongmei Zhang, Jingrong Lin, Yulin Chao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-018-0842-z"}], "href": "https://doi.org/10.1186/s13046-018-0842-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30055641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30055641"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Elena Weibert, Tobias Hofmann, Andreas Stengel "}, {"type": "b", "children": [{"type": "t", "text": "Role of nesfatin-1 in anxiety, depression and the response to stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychoneuroendocrinology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.psyneuen.2018.09.037"}], "href": "https://doi.org/10.1016/j.psyneuen.2018.09.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30292960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30292960"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Radzisław Mierzyński, Elżbieta Poniedziałek-Czajkowska, Dominik Dłuski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 and Vaspin as Potential Novel Biomarkers for the Prediction and Early Diagnosis of Gestational Diabetes Mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms20010159"}], "href": "https://doi.org/10.3390/ijms20010159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30621139"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30621139"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Z-Z Wang, S-C Chen, X-B Zou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nesfatin-1 alleviates acute lung injury through reducing inflammation and oxidative stress via the regulation of HMGB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202005_21200"}], "href": "https://doi.org/10.26355/eurrev_202005_21200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32432771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32432771"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Aminul Islam, Barbara Adamik, Feras I Hawari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M509397200"}], "href": "https://doi.org/10.1074/jbc.M509397200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16407280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16407280"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "C Alexander Valencia, Steven W Cotten, Jinzhu Duan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of nucleobindin-1 and nucleobindin-2 by caspases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2007.12.019"}], "href": "https://doi.org/10.1016/j.febslet.2007.12.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18154733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18154733"}]}]}]}
|
| Synonyms | NEFA, HEL-S-109 |
| Proteins | NUCB2_HUMAN |
| NCBI Gene ID | 4925 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NUCB2 has 9,781 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 127 datasets.
Click the + buttons to view associations for NUCB2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NUCB2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NUCB2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NUCB2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NUCB2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NUCB2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NUCB2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NUCB2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NUCB2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NUCB2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NUCB2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NUCB2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NUCB2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NUCB2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NUCB2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NUCB2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NUCB2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NUCB2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NUCB2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing NUCB2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing NUCB2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NUCB2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NUCB2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NUCB2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NUCB2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NUCB2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of NUCB2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NUCB2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for NUCB2 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NUCB2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NUCB2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NUCB2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NUCB2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NUCB2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NUCB2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NUCB2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NUCB2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NUCB2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NUCB2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NUCB2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NUCB2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NUCB2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NUCB2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NUCB2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NUCB2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NUCB2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NUCB2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NUCB2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding NUCB2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NUCB2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NUCB2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NUCB2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NUCB2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NUCB2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NUCB2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of NUCB2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NUCB2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NUCB2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with NUCB2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NUCB2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NUCB2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NUCB2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NUCB2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for NUCB2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NUCB2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NUCB2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NUCB2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of NUCB2 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NUCB2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with NUCB2 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with NUCB2 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NUCB2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NUCB2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NUCB2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NUCB2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NUCB2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NUCB2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NUCB2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NUCB2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NUCB2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NUCB2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NUCB2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NUCB2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NUCB2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing NUCB2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NUCB2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NUCB2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting NUCB2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NUCB2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NUCB2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NUCB2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NUCB2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NUCB2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NUCB2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NUCB2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NUCB2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NUCB2 protein from the Wikipathways PFOCR 2024 dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of NUCB2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NUCB2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NUCB2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NUCB2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NUCB2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NUCB2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NUCB2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NUCB2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NUCB2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NUCB2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with NUCB2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NUCB2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NUCB2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NUCB2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NUCB2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NUCB2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NUCB2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NUCB2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NUCB2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NUCB2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NUCB2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NUCB2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NUCB2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for NUCB2 from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with NUCB2 from the Virus MINT Protein-Virus Interactions dataset. | |